Abstract
Nanoscale objects of increasing complexity can be constructed from DNA or RNA. However, the scope of potential applications could be enhanced by expanding beyond the moderate chemical diversity of natural nucleic acids. Here, we explore the construction of nano‐objects made entirely from alternative building blocks: synthetic genetic polymers not found in nature, also called xeno nucleic acids (XNAs). Specifically, we describe assembly of 70 kDa tetrahedra elaborated in four different XNA chemistries (2′‐fluro‐2′‐deoxy‐ribofuranose nucleic acid (2′F‐RNA), 2′‐fluoroarabino nucleic acids (FANA), hexitol nucleic acids (HNA), and cyclohexene nucleic acids (CeNA)), as well as mixed designs, and a ∼600 kDa all‐FANA octahedron, visualised by electron microscopy. Our results extend the chemical scope for programmable nanostructure assembly, with implications for the design of nano‐objects and materials with an expanded range of structural and physicochemical properties, including enhanced biostability.
Keywords: chemical biology, DNA nanotechnology, electron microscopy, self-assembly, xeno nucleic acids (XNAs)
Nucleic acids are molecules of astonishing versatility. In addition to their well‐known roles in genetic information storage and propagation, they can act as sensors,1 catalysts,2 and regulators of gene expression.3 Furthermore, longer DNA and RNA polymers can fold into highly complex three‐dimensional (3 D) structures.4, 5 Together with the well‐understood Watson–Crick self‐association rules, this has enabled the use of nucleic acids (initially DNA, but increasingly RNA) as a scaffold for construction of nanoscale objects and devices,6, 7, 8 including polyhedra and lattices,9, 10 2 D and 3 D origami objects,11 and DNA brick structures.12 Such programmable, self‐assembling DNA and RNA nanostructures have shown potential for a wide variety of applications,13 including sensing,14 in vivo computation,15 siRNA delivery,16, 17 encapsulation and release of therapeutic cargo,18, 19, 20 organisation of biosynthetic enzymes on supramolecular assemblies,21, 22 or even formation of membrane‐spanning pores.23 However, the comparatively low biostability24 and immunogenicity25 of natural nucleic acids, together with limited chemical diversity and constraints on architecture and self‐assembly dynamics,26 restrict the scope of potential applications of DNA and RNA nanotechnology. Although some improvements might be gained though novel design strategies29 or sporadic incorporation of DNA modifications,30, 31, 32 we reasoned that a broad expansion of the range of nucleic acid chemistries available for nanotechnology could allow designs to exploit physicochemical properties beyond those of natural polymers.
Here, we report the construction of nanotechnology objects with wholesale replacement of natural nucleic acid strands with unnatural analogues, specifically synthetic genetic polymers, also known as xeno nucleic acids (XNAs). XNAs have previously been shown to be capable of XNA–XNA duplex formation33, 34 and can fold into 3 D structures, forming ligands (aptamers)28, 35, 36 and catalysts (XNAzymes).37 This offers a range of divergent structures and properties38 of potential benefit to biotechnology and medicine.39 However, de novo design in the absence of detailed knowledge on XNA structural and conformational parameters is challenging. Hybrid nanostructures based on DNA designs have previously been demonstrated to retain overall architecture, despite invasion by strands composed of, inter alia, peptide nucleic acids (PNA)41, 42, 43 or phosphorothioate DNA (PS‐DNA).32 Furthermore, a functional Phi29 DNA‐packing motor can be assembled with partial substitution of RNA components with 2′‐fluro‐2′‐deoxy‐ribofuranose nucleic acid (2′F‐RNA).44 These results indicate that, at least in some cases, structures and folding topologies can be maintained when using artificial polymers. We therefore sought to explore the potential for well‐established DNA nanotechnology designs to form self‐assembling nanostructures entirely composed of XNA strands. Using a series of engineered polymerases,28, 37, 45 we first synthesised fully XNA‐substituted analogues of the four 55‐mer strand components of the classic Turberfield DNA tetrahedron,27 elaborated in four different XNA chemistries: 2′F‐RNA, 2′‐fluoroarabino nucleic acids (FANA),46 hexitol nucleic acids (HNA), and cyclohexene nucleic acids (CeNA),33 verified by mass spectrometry (Figure S1 in the Supporting Information). Despite their known structural and conformational differences,38 all four XNA chemistries formed tetrahedra under physiological conditions in a single‐step reaction, as determined by a non‐denaturing gel electrophoresis mobility shift assay (EMSA; Figure 1). Indeed, strands composed of 2′F‐RNA and FANA (which preferentially adopt A‐form and B‐form duplexes, respectively34, 47) were even able to substitute for DNA strands in mixed‐chemistry structures (Figure S2), suggesting an ability of robust designs to overcome conformational preferences. To further verify the correct assembly and global structures of the assembled XNA tetrahedra, we coupled gold nanoparticles (AuNPs) to each vertex and imaged the resulting nano‐objects by transmission electron microscopy (TEM, Figure 2) according to a simple quasi‐3 D imaging method.40 Intact tetrahedra could be distinguished as 3 D structures from 2 D partially assembled versions in non‐annealed samples (Figure S3) by examining the relative parallax motion of AuNPs as sample grids were tilted.
To demonstrate advantageous XNA‐specific properties, we incubated tetrahedra composed of DNA or HNA in serum‐containing cell culture media at 37 °C and examined degradation by agarose gel electrophoresis (Figure S4). Although assembly into tetrahedra48 or more complex designs29 has been observed to offer some degree of protection by itself, DNA tetrahedra were fully degraded after 1–2 days, whereas HNA tetrahedra remained intact even after 8 days.
Many DNA nanostructures employ an origami‐like strategy in which a long polymer is folded into a 3 D shape through intramolecular interactions, defined by short DNA staple strands.11 In order to examine whether XNAs would be capable of origami folding, we synthesised the 1.7 kb main chain and the five 40‐mer staple strands that comprise a designed DNA octahedron49 by using exclusively FANA chemistry (Figure S5). The DNA octahedron has a branched‐tree design held together by paranemic and double‐strand crossover junctions (see ref. 49 for full details) that can be induced to fold into the octahedron upon addition of magnesium counterions (Mg2+). The FANA octahedron displayed essentially identical Mg2+‐dependent folding behaviour compared to the DNA version, as judged by EMSA (Figure 3).
In order to verify assembly and examine the effect of FANA chemistry on octahedron topology and structure, we visualised all‐FANA octahedra by using negative‐stain TEM (Figure 4). We readily identified structures resembling TEM images of DNA octahedra49 and were able to generate a 3 D model by single‐particle reconstruction at ∼30 Å resolution. This revealed a 180 Å cage‐like structure consistent with the overall design, albeit with potential alternative conformations (Figure S6) and deviating from a regular octahedron by curvature of the twelve struts comprising the octahedron edges. This might be due to the structural differences between FANA and DNA, such as the increased rigidity and non‐canonical O4′‐endo (east) conformation of the fluorinated arabinose sugar and enhanced inter‐residual interactions,34 whose effect on the architecture of crossover junctions has yet to be studied.
In summary, we describe the first elaboration of nucleic acid nanostructures using entirely synthetic XNA building blocks. Our work shows that, unlike DNA and RNA ligands and catalysts obtained by in vitro evolution, at least some DNA designs can be converted into broadly equivalent XNA nanostructures. It is too early to predict if this will be a general finding or be restricted to exceptionally flexible and robust designs. Indeed, even within the designs explored herein, differences between the structures of DNA and FANA octahedra were evident. In the case of the tetrahedron, we observed that designs with two unpaired nucleotide vertex hinges27 folded with much higher yields than those comprising single residue hinges50 (data not shown), presumably because this more constrained design was less able to accommodate the divergent structural preferences of these XNAs. As with RNA,51 a fuller realisation of the potential of novel construction materials for nanotechnology will require a more detailed investigation of the chemistry‐specific structural and conformational parameters, for which current knowledge is sparse. The XNA nanostructures described herein present clear opportunities to derive such parameters in the future, for example, through higher resolution electron microscopy structures.
The wider introduction of XNA chemistries into the design and assembly of nanotechnology objects thus promises not only an expansion of chemical diversity beyond DNA and RNA but of structural and physicochemical parameters relevant to a variety of applications, from medicine to materials science.
Supporting information
Acknowledgements
This work was supported by the Medical Research Council (program no. U105178804 to P.H.) and by grants from the European Science Foundation (ESF) and the Biotechnology and Biological Sciences Research Council (09‐EuroSYNBIO‐OP‐013 and INTENSIFY BB/M005623/1 to A.I.T.) and Cancer Research UK (C12209A16749 to E.P.M.) We would like to thank Christos Savva, Xiao‐Chen Bai, and Sjores Scheres (MRC Laboratory of Molecular Biology) and Richard Berry (University of Oxford) for useful discussions and advice.
A. I. Taylor, F. Beuron, S.-Y. Peak-Chew, E. P. Morris, P. Herdewijn, P. Holliger, ChemBioChem 2016, 17, 1107.
Contributor Information
Dr. Alexander I. Taylor, Email: alex.taylor@concordia.ca
Dr. Philipp Holliger, Email: ph1@mrc-lmb.cam.ac.uk
References
- 1. Serganov A., Nudler E., Cell 2013, 152, 17–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Breaker R. R., Joyce G. F., Chem. Biol. 2014, 21, 1059–1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Cech T. R., Steitz J. A., Cell 2014, 157, 77–94. [DOI] [PubMed] [Google Scholar]
- 4. Nissen P., Hansen J., Ban N., Moore P. B., Steitz T. A., Science 2000, 289, 920–930. [DOI] [PubMed] [Google Scholar]
- 5. Fica S. M., Mefford M. A., Piccirilli J. A., Staley J. P., Nat. Struct. Mol. Biol. 2014, 21, 464–471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Zhang F., Nangreave J., Liu Y., Yan H., J. Am. Chem. Soc. 2014, 136, 11198–11211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Grabow W. W., Jaeger L., Acc. Chem. Res. 2014, 47, 1871–1880. [DOI] [PubMed] [Google Scholar]
- 8. Jones M. R., Seeman N. C., Mirkin C. A., Science 2015, 347, 1260901. [DOI] [PubMed] [Google Scholar]
- 9. Seeman N. C., J. Theor. Biol. 1982, 99, 237–247. [DOI] [PubMed] [Google Scholar]
- 10. Chworos A., Severcan I., Koyfman A. Y., Weinkam P., Oroudjev E., Hansma H. G., Jaeger L., Science 2004, 306, 2068–2072. [DOI] [PubMed] [Google Scholar]
- 11. Rothemund P. W. K., Nature 2006, 440, 297–302. [DOI] [PubMed] [Google Scholar]
- 12. Ke Y., Ong L. L., Shih W. M., Yin P., Science 2012, 338, 1177–1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Lo P. K., Metera K. L., Sleiman H. F., Curr. Opin. Chem. Biol. 2010, 14, 597–607. [DOI] [PubMed] [Google Scholar]
- 14. Pei H., Zuo X., Pan D., Shi J., Huang Q., Fan C., NPG Asia Mater. 2013, 5, e51. [Google Scholar]
- 15. Amir Y., Ben-Ishay E., Levner D., Ittah S., Abu-Horowitz A., Bachelet I., Nat. Nanotechnol. 2014, 9, 353–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Walsh A. S., Yin H., Erben C. M., Wood M. J. A., Turberfield A. J., ACS Nano 2011, 5, 5427–5432. [DOI] [PubMed] [Google Scholar]
- 17. Afonin K. A., Viard M., Koyfman A. Y., Martins A. N., Kasprzak W. K., Panigaj M., Desai R., Santhanam A., Grabow W. W., Jaeger L., Heldman E., Reiser J., Chiu W., Freed E. O., Shapiro B. A., Nano Lett. 2014, 14, 5662–5671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Erben C. M., Goodman R. P., Turberfield A. J., Angew. Chem. Int. Ed. 2006, 45, 7414–7417; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006, 118, 7574–7577. [Google Scholar]
- 19. Douglas S. M., Bachelet I., Church G. M., Science 2012, 335, 831–834. [DOI] [PubMed] [Google Scholar]
- 20. Zhao Y.-X., Shaw A., Zeng X., Benson E., Nyström A. M., Högberg B., ACS Nano 2012, 6, 8684–8691. [DOI] [PubMed] [Google Scholar]
- 21. Fu J., Yang Y. R., Johnson Buck A., Liu M., Liu Y., Walter N. G., Woodbury N. W., Yan H., Nat. Nanotechnol. 2014, 9, 531–536. [DOI] [PubMed] [Google Scholar]
- 22. Sachdeva G., Garg A., Godding D., Way J. C., Silver P. A., Nucleic Acids Res. 2014, 42, 9493–9503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Langecker M., Arnaut V., Martin T. G., List J., Renner S., Mayer M., Dietz H., Simmel F. C., Science 2012, 338, 932–936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Hahn J., Wickham S. F. J., Shih W. M., Perrault S. D., ACS Nano 2014, 8, 8765–8775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Surana S., Shenoy A. R., Krishnan Y., Nat. Nanotechnol. 2015, 10, 741–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Pinheiro A. V., Han D., Shih W. M., Yan H., Nat. Nanotechnol. 2011, 6, 763–772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Goodman R. P., Berry R. M., Turberfield A. J., Chem. Commun. 2004, 1372–1373. [DOI] [PubMed] [Google Scholar]
- 28. Pinheiro V. B., Taylor A. I., Cozens C., Abramov M., Renders M., Zhang S., Chaput J. C., Wengel J., Peak-Chew S. Y., McLaughlin S. H., Herdewijn P., Holliger P., Science 2012, 336, 341–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Cassinelli V., Oberleitner B., Sobotta J., Nickels P., Grossi G., Kempter S., Frischmuth T., Liedl T., Manetto A., Angew. Chem. Int. Ed. 2015, 54, 7795–7798; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2015, 127, 7905–7909. [Google Scholar]
- 30. Conway J. W., McLaughlin C. K., Castor K. J., Sleiman H., Chem. Commun. 2013, 49, 1172–1174. [DOI] [PubMed] [Google Scholar]
- 31. Peters J. P., Yelgaonkar S. P., Srivatsan S. G., Tor Y., Maher L. J., Nucleic Acids Res. 2013, 41, 10593–10604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Burns J. R., Stulz E., Howorka S., Nano Lett. 2013, 13, 2351–2356. [DOI] [PubMed] [Google Scholar]
- 33. Herdewijn P., Chem. Biodiversity 2010, 7, 1–59. [DOI] [PubMed] [Google Scholar]
- 34. Martin-Pintado N., Yahyaee-Anzahaee M., Campos-Olivas R., Noronha A. M., Wilds C. J., Damha M. J., Gonzalez C., Nucleic Acids Res. 2012, 40, 9329–9339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Alves Ferreira-Bravo I., Cozens C., Holliger P., DeStefano J. J., Nucleic Acids Res. 2015, 43, 9587–9599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Yu H., Zhang S., Chaput J. C., Nat. Chem. 2012, 4, 183–187. [DOI] [PubMed] [Google Scholar]
- 37. Taylor A. I., Pinheiro V. B., Smola M. J., Morgunov A. S., Peak-Chew S., Cozens C., Weeks K. M., Herdewijn P., Holliger P., Nature 2015, 518, 427–430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Anosova I., Kowal E. A., Dunn M. R., Chaput J. C., Van Horn W. D., Egli M., Nucleic Acids Res. 2016, 44, 1007–1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Taylor A. I., Arangundy-Franklin S., Holliger P., Curr. Opin. Chem. Biol. 2014, 22, 79–84. [DOI] [PubMed] [Google Scholar]
- 40. Stern A., Rotem D., Popov I., Porath D., J. Phys. Condens. Matter 2012, 24, 164203. [DOI] [PubMed] [Google Scholar]
- 41. Yamazaki T., Aiba Y., Yasuda K., Sakai Y., Yamanaka Y., Kuzuya A., Ohya Y., Komiyama M., Chem. Commun. 2012, 48, 11361–11363. [DOI] [PubMed] [Google Scholar]
- 42. Flory J. D., Johnson T., Simmons C. R., Lin S., Ghirlanda G., Fromme P., Artif. DNA PNA XNA 2014, 5(3), 1–8. [DOI] [PubMed] [Google Scholar]
- 43. Pedersen R. O., Kong J., Achim C., LaBean T. H., Molecules 2015, 20, 17645–17658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Liu J., Guo S., Cinier M., Shlyakhtenko L. S., Shu Y., Chen C., Shen G., Guo P., ACS Nano 2011, 5, 237–246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cozens C., Pinheiro V. B., Vaisman A., Woodgate R., Holliger P., Proc. Natl. Acad. Sci. USA 2012, 109, 8067–8072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Wilds C. J., Damha M. J., Nucleic Acids Res. 2000, 28, 3265–3625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Pallan P. S., Greene E. M., Jicman P. A., Pandey R. K., Manoharan M., Rozners E., Egli M., Nucleic Acids Res. 2011, 39, 3482–3495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Keum J.-W., Bermudez H., Chem. Commun. 2009, 0, 7036–7038. [DOI] [PubMed] [Google Scholar]
- 49. Shih W. M., Quispe J. D., Joyce G. F., Nature 2004, 427, 618–621. [DOI] [PubMed] [Google Scholar]
- 50. Kato T., Goodman R. P., Erben C. M., Turberfield A. J., Namba K., Nano Lett. 2009, 9, 2747–2750. [DOI] [PubMed] [Google Scholar]
- 51. Zuo H., Wu S., Li M., Li Y., Jiang W., Mao C., Angew. Chem. Int. Ed. 2015, 54, 15118–15121; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2015, 127, 15333–15336. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.